… in remission at 8 years. And, 45% of newly diagnosed patients in this study remained in
remission … or durable as in patients who did not receive rituximab plus chemotherapy induction. …

… Follicular lymphoma (FL) is the second most frequent NHL subtype. Patients who relapse …
R/R FL and were often durable. Here, we report the incidence and durability of responses in …

… remission at eight years with 45 percent of newly diagnosed patients in this study in remission
… high or durable as in patients who did not receive rituximab plus chemotherapy induction. …

… durable remission and cure, the sequential application of effective, non-cross-resistant treat…
It is essential that physicians treating patients with follicular lymphoma demonstrate restraint …

… Complete remission was the most important factor for … in their first remission, raising the issue
of curability in follicular … achievement of a strong and durable response may favorably affect …

… (FL) is the most common indolent non-Hodgkin lymphoma (NHL), accounting for ∼… Lymphoma
Group (NLG) demonstrated that rituximab monotherapy can produce durable remissions …

… to provide durable complete remissions that can lead towards survival improvement and
perhaps cure. Given the long-term survival of these patients, preference should also be given to …

… treatment options for common lymphoma subtypes taking into … We focus on follicular
lymphoma, diffuse large B-cell lymphoma … studies documented long-lasting remissions in patients …

… Follicular lymphoma (FL) is the second most common B-cell non-Hodgkin lymphoma (NHL)
and the most common … Follow-up of PRIMA study suggesting durable remission with RM. …

… common type of non-Hodgkin's lymphoma (NHL) and accounts for 25% of lymphoma cases
in … within the first year of therapy correlate with durable clinical remissions, (iii) the degree or …